Current status of immune checkpoint inhibitors in treatment of non-small cell lung cancer
Sung Won Lim, Myung-Ju Ahn
Korean J Intern Med. 2019;34(1):50-59. Published online 2018 Sep 3 DOI: https://doi.org/10.3904/kjim.2018.179
Citations to this article as recorded by 
Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer
Gian Marco Leone, Saverio Candido, Alessandro Lavoro, Silvia Vivarelli, Giuseppe Gattuso, Daniela Calina, Massimo Libra, Luca Falzone
Pharmaceutics.2023; 15(4): 1252. CrossRef
Recent Advances in Chemotherapy Combined with Immunotherapy for Non-Small Cell Lung Cancer
隽军 邓
Advances in Clinical Medicine.2023; 13(08): 13645. CrossRef
Perioperative immunotherapy in stage IB-III non-small cell lung cancer: a critical review of its rationale and considerations
Jae Kyeom Sim, Juwhan Choi, Sung Yong Lee
The Korean Journal of Internal Medicine.2023; 38(6): 787. CrossRef
Nanomedicine-Based Gene Delivery for a Truncated Tumor Suppressor RB94 Promotes Lung Cancer Immunity
Sang-Soo Kim, Caroline Doherty, Manish Moghe, Antonina Rait, Kathleen F. Pirollo, Joe B. Harford, Esther H. Chang
Cancers.2022; 14(20): 5092. CrossRef
Combination of the EP and Anti-PD-1 Pathway or Anti-CTLA-4 for the Phase III Trial of Small-Cell Lung Cancer: A Meta-Analysis
Abdulhakim A. A. Abunasser, Jinmin Xue, Ehab J. A. Balawi, Yuxi Zhu, Yuan Seng Wu
Journal of Oncology.2021; 2021: 1. CrossRef
hsa_circ_0003222 accelerates stemness and progression of non-small cell lung cancer by sponging miR-527
Changhui Li, Jiaqi Zhang, Xiaohua Yang, Cheng Hu, Tianqing Chu, Runbo Zhong, Yinchen Shen, Fang Hu, Feng Pan, Jianlin Xu, Jun Lu, Xiaoxuan Zheng, Hai Zhang, Wei Nie, Baohui Han, Xueyan Zhang
Cell Death & Disease.2021;[Epub] CrossRef
Common phenotypic dynamics of tumor-infiltrating lymphocytes across different histologies upon checkpoint inhibition: impact on clinical outcome
Vinicius Araujo B. de Lima, Annie Borch, Morten Hansen, Arianna Draghi, Iben Spanggaard, Kristoffer Rohrberg, Sine Reker Hadrup, Ulrik Lassen, Inge Marie Svane
Cytotherapy.2020; 22(4): 204. CrossRef
Pattern-of-failure and salvage treatment analysis after chemoradiotherapy for inoperable stage III non-small cell lung cancer
Julian Taugner, Chukwuka Eze, Lukas Käsmann, Olarn Roengvoraphoj, Kathrin Gennen, Monika Karin, Oleg Petrukhnov, Amanda Tufman, Claus Belka, Farkhad Manapov
Radiation Oncology.2020;[Epub] CrossRef
TGF-β induced EMT and stemness characteristics are associated with epigenetic regulation in lung cancer
Bit Na Kim, Dong Hyuck Ahn, Nahyeon Kang, Chang Dong Yeo, Young Kyoon Kim, Kyo Young Lee, Tae-Jung Kim, Sug Hyung Lee, Mi Sun Park, Hyeon Woo Yim, Jong Y. Park, Chan Kwon Park, Seung Joon Kim
Scientific Reports.2020;[Epub] CrossRef
Biomarkers or factors for predicting the efficacy and adverse effects of immune checkpoint inhibitors in lung cancer: achievements and prospective
Wen-Jia Shi, Wei Zhao
Chinese Medical Journal.2020; 133(20): 2466. CrossRef
Hypoxia-induced cancer stemness acquisition is associated with CXCR4 activation by its aberrant promoter demethylation
Nahyeon Kang, Su Yeon Choi, Bit Na Kim, Chang Dong Yeo, Chan Kwon Park, Young Kyoon Kim, Tae-Jung Kim, Seong-Beom Lee, Sug Hyung Lee, Jong Y. Park, Mi Sun Park, Hyeon Woo Yim, Seung Joon Kim
BMC Cancer.2019;[Epub] CrossRef
Pretreatment albumin/fibrinogen ratio as a promising predictor for the survival of advanced non small-cell lung cancer patients undergoing first-line platinum-based chemotherapy
Jun Ying, Danfei Zhou, Tongjie Gu, Jianda Huang, Haijian Liu
BMC Cancer.2019;[Epub] CrossRef